College of Pharmacy adds new practice partner

The University of Cincinnati James L. Winkle College of Pharmacy has created a new partnership with Primary Health Solutions (PHS),a federally qualified health center with multiple locations in Southeastern Ohio. This new collaboration provides additional practice and training sites for faculty, students and pharmacy practice residents.

“This is a new opportunity to train students and residents in underserved populations, a new practice area with a pharmacist imbedded within a primary care team,” says the college’s residency program director and professor of pharmacy practice, Bethanne Brown, PharmD. 

PHS is a non-profit, safety-net health care provider serving Butler County with centers in Hamilton, Fairfield, Middletown and Oxford and has a new location opening soon in Dayton. PHS offers a comprehensive range of health care services, on a sliding-fee scale, to all residents of Butler County regardless of income or insurance coverage. 

Brown will serve as one of three pharmacists overseeing pharmacy students on rotation and pharmacy residents. 

Traditionally, Brown says, most people think of pharmacies as brick and mortar stores. But pharmacies also exist in hospitals, long-term care facilities and primary care practices.

With the addition of PHS, the college currently partners with four community pharmacy practice partners for the residency program including: St. Vincent de Paul Charitable Pharmacy, Five Rivers Health Center and Med Managers/LifeLine. 

The college has an excellent placement rate for all graduates of its residency programs prior to the completion of the residency year, Brown says.

The Winkle College of Pharmacy is one of the oldest pharmacy colleges in the United States. It is located on the University of Cincinnati Medical Campus with the colleges of Medicine, Nursing, and Allied Health Sciences.

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.